Open AccessHormone receptors and human epidermal growth factor (HER2) expression in fine-needle aspirates from metastatic breast carcinoma – Role in patient management
Author(s) -
Issam M. Francis,
Rabeah Al-Temaimi,
Bushra Al-Ayadhy,
Preeta Alath,
Mohammed Jaragh,
Fatma Jasem Mothafar,
Kusum Kapila
Publication year - 2019
Publication title -
journal of cytology/journal of cytology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.267
H-Index - 19
eISSN - 0974-5165
pISSN - 0970-9371
DOI - 10.4103/joc.joc_117_18
Subject(s) - medicine , immunohistochemistry , estrogen receptor , breast carcinoma , pathology , progesterone receptor , metastasis , breast cancer , metastatic breast cancer , oncology , cancer
Estrogen receptors (ER), progesterone receptors (PR), and epidermal growth factor (HER2) are prognostic and predictive factors for breast carcinoma. We determined them by immunohistochemistry (IHC) on cell blocks from fine-needle aspirates (FNA) of metastatic breast carcinoma to axillary lymphnodes and compared them with that reported in the primary breast carcinoma (PBC) to document any change in their expression for future management.